DOW JONES26,957.59-123.77 -0.46%
S&P 5003,116.39-11.82 -0.38%
NASDAQ8,980.78+15.16 0.17%

Craig-Hallum Initiates Coverage On Avadel Pharmaceuticals with Buy Rating, Announces $15 Price Target

Craig-Hallum analyst Francois Brisebois initiates coverage on Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy rating and a $15 price target.

Benzinga · 01/30/2020 15:38

Craig-Hallum analyst Francois Brisebois initiates coverage on Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy rating and a $15 price target.